CAS 88455-08-7: (2S)-3-methyl-2-{[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino}butanoic acid (non-preferred name)

N-Valinyl-1-deoxy-D-glucitol is an inhibitor of protein glycosylation. It prevents the formation of N-glycans on proteins by inhibiting the addition of glucose from UDP-glucose to proteins. This leads to a reduction in the total carbohydrate content of cell membranes and other glycoconjugates. N-Valinyl-1-deoxy-D-glucitol has been shown to be useful for reducing blood sugar levels in diabetic patients, as well as decreasing serum concentrations of hemoglobins and serum albumin in these patients. The use of N-Valinyl-1-deoxy-D-glucitol has also been shown to reduce glycosylation of human albumin, leading to an increase in its solubility. This drug can be used as a control substance for antihuman IgG polyclonal antibody assays.